Mutation analysis of factor VIII in Korean patients with severe hemophilia A

被引:7
作者
You, Chur-Woo [5 ]
Son, Hee-Sook [5 ]
Kim, Hee Jin [4 ]
Woo, Eui-Jeon [3 ]
Kim, Soon-Ae [2 ]
Baik, Haing-Woon [1 ]
机构
[1] Eulji Univ, Sch Med, Dept Biochem & Mol Biol, Taejon 301832, South Korea
[2] Eulji Univ, Sch Med, Dept Pharmacol, Taejon 301832, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Lab Med, Seoul, South Korea
[5] Eulji Univ, Sch Med, Dept Pediat, Taejon 301832, South Korea
关键词
Severe hemophilia A; Korean; Factor VIII; Mutation; INHIBITOR DEVELOPMENT; INVERSION HOTSPOT; MOLECULAR-BASIS; GENE; IDENTIFICATION; SITE; POLYMORPHISMS; RECOMBINANT; DIAGNOSIS; RESIDUES;
D O I
10.1007/s12185-010-0593-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophilia A is an X-linked recessive disorder caused by mutations of the factor VIII gene. The mutation spectrum has been reported in various populations, but not in Koreans. Mutation analysis of the factor VIII gene was performed in 22 unrelated Korean patients with severe hemophilia A. We extracted genomic DNA from their blood, and assessed intron inversions, deletions, and point mutations by direct DNA sequencing. A multiplex ligation-dependent probe amplification gene dosage assay was also performed to identify exon deletions. Disease-causing mutations were identified in all patients, of which four cases were previously unreported. Seven intron 22 inversions, nine point mutations (6 nonsense mutations and 3 missense mutations), and four small rearrangements were identified. One multi-exon deletion and one 5'-donor splicing site mutation were also observed. Four novel mutations (one small deletion, one multiple exon deletion, one missense, and one splice site mutation) were detected, and point mutations were predominant (40.9%), followed by intron 22 inversions (31.8%). Further studies are required in order to establish a solid conclusion regarding the prevalence of various mutations in the Korean population.
引用
收藏
页码:784 / 791
页数:8
相关论文
共 50 条
  • [41] Identification of the Intron 22 and Intron 1 Inversions of the Factor VIII Gene in Iraqi Kurdish Patients With Hemophilia A
    Abdulqader, Aveen M. Raouf
    Mohammed, Ali Ibrahim
    Rachid, Shwan
    Ghoraishizadeh, Peyman
    Mahmood, Sarwar Noori
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [42] Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A
    Andrikovics, H
    Klein, I
    Bors, A
    Nemes, L
    Marosi, A
    Váradi, A
    Tordai, A
    HAEMATOLOGICA, 2003, 88 (07) : 778 - 784
  • [43] Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement
    Spena, S.
    Garagiola, I.
    Cannavo, A.
    Mortarino, M.
    Mannucci, P. M.
    Rosendaal, F. R.
    Peyvandi, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (04) : 778 - 790
  • [44] Factor VIII gene mutations profile in 148 Chinese hemophilia A subjects
    Xue, Feng
    Zhang, Lei
    Sui, Tao
    Ge, Jing
    Gu, Dongsheng
    Du, Weiting
    Zhao, Haifeng
    Yang, Renchi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (03) : 264 - 272
  • [45] Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies for Hemophilia A Patients
    Khalilian, Sheyda
    Motovali-Bashi, Majid
    Rezaie, Halimeh
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2020, 9 (01) : 33 - 49
  • [46] Low-dose immune tolerance induction in children with severe hemophilia A with high-titer inhibitors: Type of factor 8 mutation and outcomes
    Sun, Jie
    Li, Zekun
    Li, Gang
    Huang, Kun
    Ai, Di
    Liu, Guoqing
    Yao, Wanru
    Xie, Xingjuan
    Gu, Hao
    Zhen, Yingzi
    Chen, Zhenping
    Wu, Runhui
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2022, 6 (07)
  • [47] Application of new molecular methods in detection of Intron 22 inversion mutation of factor VIII gene in patients with Hemophilia A
    Mousavi, Seyed Hamid
    Namin, Seyed Alireza Mesbah
    Ala, Fereidoon
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S97 - S97
  • [48] Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A
    Oldenburg, Johannes
    Chambost, Herve
    Liu, Hai
    Hawes, Charles
    You, Xiaojun
    Yang, Xinqun
    Newman, Vanessa
    Robinson, Tara M.
    Hatswell, Anthony J.
    Hinds, David
    Santos, Sandra
    Ozelo, Margareth
    ADVANCES IN THERAPY, 2024, 41 (06) : 2267 - 2281
  • [49] Antibodies with hydrolytic activity towards factor VIII in patients with hemophilia A
    Lacroix-Desmazes, S
    Misra, N
    Bayry, J
    Villard, S
    Kazatchkine, MD
    Kaveri, SV
    JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 269 (1-2) : 251 - 256
  • [50] Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay
    Boylan, B.
    Rice, A. S.
    Dunn, A. L.
    Tarantino, M. D.
    Brettler, D. B.
    Barrett, J. C.
    Miller, C. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (01) : 47 - 53